Preclinical testing of farletuzumab ecteribulin (FZEC [MORAb-202]) and MORAb-109, folate receptor a and mesothelin targeting antibody-drug conjugates (ADCs), in rare gynecologic cancers.
Farletuzumab Ecteribulin;MORAB-109
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Preclinical testing of farletuzumab ecteribulin (FZEC [MORAb-202]) and MORAb-109, folate receptor a and mesothelin targeting antibody-drug conjugates (ADCs), in rare gynecologic cancers. ### Output: Farletuzumab Ecteribulin;MORAB-109